These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6791499)

  • 1. Effects of psychotropic drugs on intelligence test performance of institutionalized mentally retarded adults.
    Breuning SE; Davidson NA
    Am J Ment Defic; 1981 May; 85(6):575-9. PubMed ID: 6791499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
    Breuning SE; Ferguson DG; Cullari S
    Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?
    Mahan S; Holloway J; Bamburg JW; Hess JA; Fodstad JC; Matson JL
    Res Dev Disabil; 2010; 31(6):1561-9. PubMed ID: 20542660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders.
    Langee HR
    Am J Ment Retard; 1990 Jan; 94(4):448-52. PubMed ID: 2105098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term usefulness of thioridazine for institutionalized mentally retarded patients.
    Heistad GT; Zimmermann RL; Doebler MI
    Am J Ment Defic; 1982 Nov; 87(3):243-51. PubMed ID: 7180884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurological tolerance of lithium-psychotropic drugs association (author's transl)].
    Braccini T; Coat C; Lavagna J; Myquel M; Darcourt G
    Encephale; 1981; 7(1):29-43. PubMed ID: 7227283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.
    Aman MG; Teehan CJ; White AJ; Turbott SH; Vaithianathan C
    Am J Ment Retard; 1989 Jan; 93(4):452-60. PubMed ID: 2649118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced dystonia.
    Swett C
    Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy with psychotropic agents of mentally retarded children].
    Kinze W
    Z Arztl Fortbild (Jena); 1983; 77(9):402-4. PubMed ID: 6880286
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of psychotropic drug, response cost, and psychotropic drug plus response cost procedures for controlling institutionalized mentally retarded persons.
    Breuning SE; O'Neill MJ; Ferguson DG
    Appl Res Ment Retard; 1980; 1(3-4):253-68. PubMed ID: 7337461
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal of chronic chlorpromazine medication: an experimental analysis.
    Marholin D; Touchette PE; Stewart RM
    J Appl Behav Anal; 1979; 12(2):159-71. PubMed ID: 489476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate and inappropriate use of psychotherapeutic medications for institutionalized mentally retarded persons.
    Bates WJ; Smeltzer DJ; Arnoczky SM
    Am J Ment Defic; 1986 Jan; 90(4):363-70. PubMed ID: 3946473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social reinforcement effects on Block Design performance of organic and nonorganic retarded adults.
    Roth G; McManis DL
    Am J Ment Defic; 1972 Sep; 77(2):181-9. PubMed ID: 5081086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing test performance of moderately and severely mentally retarded adolescents and adults.
    Budoff M; Hamilton JL
    Am J Ment Defic; 1976 Jul; 81(1):49-57. PubMed ID: 941933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
    Claghorn JL
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication-induced somnambulism in a patient with schizoaffective disorder.
    Glassman JN; Darko D; Gillin JC
    J Clin Psychiatry; 1986 Oct; 47(10):523-4. PubMed ID: 3093469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of self-injurious behavior in mentally retarded persons.
    Singh NN; Millichamp CJ
    J Autism Dev Disord; 1985 Sep; 15(3):257-67. PubMed ID: 2863252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.